Skip to main content
Fig. 3 | Journal of Neuroinflammation

Fig. 3

From: Fingolimod attenuates experimental autoimmune neuritis and contributes to Schwann cell-mediated axonal protection

Fig. 3

Fingolimod protects against demyelinating damage. Electrophysiological testing of motor nerve conduction velocity (MNCV) (a) and example of nerve conduction block in the lower left corner (b). Animals were examined 1 day before immunization and at either maximum of the disease (day 17) or in the recovery phase (day 21). One to two independent experiments were performed with four animals per group. MNCV was compared using a one-way ANOVA (p < 0.0001) combined with Tukey’s multiple comparison test. ***p < 0.001

Back to article page